- •
Conduction abnormalities are common following transcatheter aortic valve replacement (TAVR), as the anatomy of the left ventricular and aortic outflow tracts predispose to damage to the conduction system during and after the procedure.
- •
Patient factors, procedural characteristics, and the type of valve used during TAVR all contribute to the need for permanent pacemaker.
- •
Careful monitoring of patients post-TAVR can help identify the patients who will require a pacemaker and minimize potential
Conduction System Abnormalities After Transcatheter Aortic Valve Replacement: Mechanism, Prediction, and Management
Section snippets
Key points
Mechanisms of conduction abnormalities following transcatheter aortic valve replacement
A detailed explanation of the mechanisms that underlie post-TAVR conduction abnormalities requires a brief overview of the anatomic structures in and around the aortic root and the LVOT, because the conduction system of the heart lies in close proximity to these structures. The aortic root is made up of the sinuses of Valsalva, the fibrous interleaflet triangles, and the valvar leaflets themselves.16 It is a direct extension of the LVOT, which is itself composed of muscular components (the
Prediction of conduction system abnormalities posttranscatheter aortic valve replacement
Preprocedural patient characteristics and peri-procedural considerations are important predictors for conduction system abnormalities following TAVR. In a large meta-analysis that included a mix of balloon-expandable and self-expanding systems implanted predominantly via the transfemoral approach, male sex, preprocedural electrocardiographic abnormalities including first-degree AV block, left-anterior hemiblock, and RBBB were significantly associated with the need for PPM. The presence of AV
Management and clinical implications
The long-term deleterious consequences of ventricular pacing are well known. In TAVR, PPM implantation has been associated with an increased risk for heart failure hospitalization, all-cause readmission, emergency department visits, days spent in the intensive care unit, overall length of stay, maintenance of a persistently reduced ejection fraction, and overall mortality.29, 30, 31 This risk may be particularly increased among patients with already reduced ejection fraction.32
One of the
Summary
Conduction disturbances are frequent following TAVR given the location of the cardiac conduction system relative to the site of transcatheter heart valve implantation. Several clinical, anatomic, electrocardiographic, and procedural characteristics are predictors for the need for PPM following TAVR. Care should be taken to limit the use of PPM given the deleterious consequences of pacing post-TAVR, and input from electrophysiology specialists should be undertaken to ensure the appropriate use
Acknowledgments
Dr V.S. Mahadevan is a Principal investigator for research studies with Edwards Life Sciences.
References (44)
- et al.
Burden of valvular heart diseases: a population-based study
Lancet
(2006) - et al.
Atrioventricular and intraventricular block after transcatheter aortic valve implantation
J Interv Card Electrophysiol
(2018) - et al.
Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis
J Am Coll Cardiol
(2014) - et al.
Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry
JACC Cardiovasc Interv
(2016) - et al.
Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation
J Am Coll Cardiol
(2012) - et al.
Initial experience of a second-generation self-expanding transcatheter aortic valve: the UK & Ireland Evolut R Implanters’ Registry
JACC Cardiovasc Interv
(2017) - et al.
Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height
JACC Cardiovasc Interv
(2016) - et al.
Early outcomes with the Evolut PRO repositionable self-expanding transcatheter aortic valve with pericardial wrap
JACC Cardiovasc Interv
(2018) - et al.
Visualizing anatomical evidences on atrioventricular conduction system for TAVI
Int J Cardiol
(2014) - et al.
Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI)
Med Eng Phys
(2013)
Implantation depth measured by 64-slice computed tomography is associated with permanent pacemaker requirement following transcatheter aortic valve implantation with the Core Valve(®) system
J Cardiol
Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the medtronic corevalve system: the corevalve prospective, International, Post-Market ADVANCE-II Study
JACC Cardiovasc Interv
Pre-existing right bundle branch block increases risk for death after transcatheter aortic valve replacement with a balloon-expandable valve
JACC Cardiovasc Interv
Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement
JACC Cardiovasc Interv
Utility of invasive electrophysiology studies in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation
Am J Cardiol
Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System
Int J Cardiol
Mortality and heart failure hospitalization in patients with conduction abnormalities after transcatheter aortic valve replacement
JACC Cardiovasc Interv
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death
J Am Coll Cardiol
Impact of short-term complications on mortality and quality of life after transcatheter aortic valve replacement
JACC Cardiovasc Interv
Spontaneous course of aortic valve disease
Eur Heart J
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery
N Engl J Med
Transcatheter versus surgical aortic-valve replacement in high-risk patients
N Engl J Med
Cited by (7)
Intraprocedural dynamics of cardiac conduction during transcatheter aortic valve implantation: Assessment by simultaneous electrophysiological testing
2021, Heart RhythmCitation Excerpt :Radial mechanical forces caused by balloon predilation, prosthesis delivery, and the self-expandable nitinol stent frame impinge on the described regions and seem to trigger the observed conduction disorders. However, in contrast to previously published data,15,28,29 we found no evidence of damage to the AV node itself. We were able to demonstrate a positive correlation between prosthesis implantation depth and the rate of new-onset LBBB.
AV Block Post-TAVR: When AV Block Is High, We Go Low (in the Conduction System)
2020, JACC: Clinical ElectrophysiologyNon-invasive predictors for infranodal conduction delay in patients with left bundle branch block after TAVR
2021, Clinical Research in CardiologyBiomechanical Identification of High-Risk Patients Requiring Permanent Pacemaker After Transcatheter Aortic Valve Replacement
2021, Frontiers in Bioengineering and BiotechnologyPR interval prolongation is significantly associated with aortic root abscess: An age- and gender-matched study
2021, Annals of Noninvasive Electrocardiology